Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in ACHV — Achieve Life Sciences, Inc.

CIK 1000275 TORONTO, A6
Back to ACHV Full portfolio

Position in ACHV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$80,815
+$80,445 QoQ
Shares Held
12,376
+9722.2% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#89
of 111 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACHV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. ACHV ranks #145 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in ACHV

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $80,815 12,376
2026-03-31 $370 126
2025-12-31 $7,633 1,536
2025-09-30 $487,368 154,720
2025-06-30 $266,530 117,934
2025-03-31 $5,013 1,878
2024-12-31 $14,642 4,160
2024-09-30 $17,106 3,609
2024-06-30 $15,223 3,239
2023-06-30 $2,595 500
2022-09-30 $111,804 33,880
2022-06-30 $245,952 50,400
2022-03-31 $305,828 40,400
2021-12-31 $322,092 41,400
2021-09-30 $271,150 31,900
2021-06-30 $275,686 30,700
2020-06-30 $2 7
2020-03-31 $2 7